Lenograstim

来格司亭

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLenograstim
Drug Alias Namelenograstim来诺拉司亭重组人粒细胞刺激因子（CHO细胞）Eutropinlenograstimum +[9] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropeniaMultiple MyelomaLymphoma, Non-Hodgkin +[4] 
Global Approved IndicationsNeutropenia
Approved Indications in ChinaNeutropenia
Original Approved Country/TerritoryJapan
Original Approved Date1991/10/04
Country/TerritorySouth KoreaMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChugai Pharmaceutical Co LtdLg Chemical Ltd
Inactive CompaniesChugai Pharma GmbhWisp Wissenschaftlicher Service Pharma Gmbh
Active IndicationsNeutropenia
Inactive IndicationsMultiple MyelomaLymphoma, Non-HodgkinHodgkin Disease

Other Information

ATC CodeL03AA10
Related LinksWikipediaDrugBankKEGG